Home

News

The U.S. Food and Drug Administration quietly approved a generic form of the chemical abortion drug mifepristone produced by a company that says its mission is to “normalize abortion,” a decision that pro-lifers have decried as a “betrayal.”

In a Tuesday letter to Evita Solutions LLC, the company that produces the drug, the FDA stated that it had conducted a review and determined that its mifepristone tablets are “bioequivalent and therapeutically equivalent” to the brand-name version, Mifeprex.

Pro-life advocates have condemned the decision, citing concerns about the loss of unborn lives and safety risks for women.

Responding to the backlash from pro-life groups, Secretary of Health and Human Services Robert F. Kennedy Jr., whose agency oversees the FDA, said in a statem

See Full Page